Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.58B | 1.57B | 1.53B | 1.28B | 910.90M | 562.70M | Gross Profit |
703.10M | 707.00M | 589.40M | 465.50M | 373.20M | 253.30M | EBIT |
255.50M | 244.60M | 218.10M | 107.10M | 107.00M | 81.00M | EBITDA |
343.40M | 328.40M | 306.00M | 180.60M | 188.70M | 147.50M | Net Income Common Stockholders |
169.50M | 160.20M | 112.70M | 61.70M | 49.70M | 35.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
144.70M | 198.00M | 136.70M | 124.80M | 96.60M | 62.30M | Total Assets |
2.61B | 2.65B | 2.67B | 2.86B | 1.08B | 3.40B | Total Debt |
556.90M | 551.60M | 543.20M | 570.10M | 539.50M | 0.00 | Net Debt |
412.20M | 353.60M | 406.50M | 445.30M | 442.90M | -62.30M | Total Liabilities |
1.06B | 1.06B | 1.06B | 1.25B | 951.30M | 1.96B | Stockholders Equity |
1.55B | 1.59B | 1.60B | 1.61B | 126.40M | 1.44B |
Cash Flow | Free Cash Flow | ||||
260.10M | 271.70M | 232.60M | 89.40M | 200.30M | 168.00M | Operating Cash Flow |
282.50M | 293.50M | 253.90M | 97.00M | 223.60M | 196.30M | Investing Cash Flow |
-22.40M | -20.20M | -4.60M | -6.60M | -21.90M | -122.50M | Financing Cash Flow |
-268.70M | -207.50M | -239.20M | -61.10M | -356.20M | -409.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.14B | 37.34 | 10.49% | 0.96% | 3.22% | 38.39% | |
78 Outperform | $6.05B | 29.06 | 18.78% | 0.52% | 7.85% | 15.78% | |
75 Outperform | $923.67M | 20.23 | 18.34% | ― | 8.89% | 278.44% | |
74 Outperform | $3.01B | 16.44 | 95.48% | 0.41% | 1.43% | 12.88% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
64 Neutral | $688.33M | 34.66 | 10.35% | ― | 10.93% | 6.99% | |
38 Underperform | $1.77B | ― | -67.71% | ― | ― | -180.10% |
On May 1, 2025, Zurn Elkay Water Solutions Corporation held its Annual Meeting of Stockholders, where several key decisions were made. Stockholders approved an amendment to the Performance Incentive Plan, increasing the shares available for issuance by 2,500,000, elected four directors for terms expiring in 2028, and ratified Ernst & Young LLP as the independent auditor for fiscal year 2025. These decisions are expected to strengthen the company’s governance and financial oversight, potentially impacting its market positioning and stakeholder confidence.